Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 70Rectal Neoplasms 29Colonic Neoplasms 28Carcinoma, Hepatocellular 26Neoplasm Metastasis 15Stomach Neoplasms 12Pancreatic Neoplasms 7Cholangiocarcinoma 6Adenocarcinoma Of Esophagus 6Esophageal Neoplasms 5Recurrence 4Liver Neoplasms 4Biliary Tract Neoplasms 4Neoplasms 3Esophageal Squamous Cell Carcinoma 3Peritoneal Neoplasms 2Neoplastic Cells, Circulating 2Gastrointestinal Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2Adenocarcinoma 2Postoperative Complications 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Pancreatic Adenocarcinoma 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Oligometastatic Gastric Adenocarcinoma 1Neurotoxicity Syndromes 1Neuropathy, Painful 1Neuralgia 1

Interventions

lenvatinib 3Surgical Procedures, Operative 3Fluorouracil 3Drug Therapy 3Oxaliplatin 2Leucovorin 2Gemcitabine 2Folfox protocol 2regorafenib 1gemcitabine-oxaliplatin regimen 1durvalumab 1donafenib 1apatinib 1Radiotherapy 1Hepatectomy 1Floxuridine 1Cryosurgery 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Cirrhosis, Familial, with Pulmonary Hypertension × Folfox protocol × Clear all
NCT07353827 2026-01-20

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Sun Yat-sen University

Phase 2 Not yet recruiting
36 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06946849 2025-04-27

SED-RO-ICC

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting
76 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡